Skip to content

13F-HR filed by Octagon Capital Advisors LP

Octagon Capital Advisors LP filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 19:22:34 UTC, with 26 holding rows worth $750,613,938.

Accession
0001839435-26-000006
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

13F report for Q3 2026

A holdings report, 26 entries on the cover page, a total value of $750,613,938 stated on the cover page (in dollars after the unit check, H1), rows summing to $750,613,938 with VALUE read as dollars as filed, 13F file number 028-20958. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
DIANTHUS THERAPEUTICS INC252828108COM1,686,667$148,511,029dollars as filed
ABIVAX SA-00370M103SPONSORED ADS993,000$98,326,860dollars as filed
DEFINIUM THERAPEUTICS INC24477V105COM SHS2,511,000$95,568,660dollars as filed
COGENT BIOSCIENCES INC19240Q201COM2,350,000$75,247,000dollars as filed
ARRIVENT BIOPHARMA INC04272N102COM2,141,387$64,841,198dollars as filed
TAYSHA GENE THERAPIES INC877619106COMMON STOCK9,693,244$47,206,098dollars as filed
Obsidian Therapeutics, Inc.67448A106Common Stock, $0.0001 par value per share2,414,610$33,152,595dollars as filed
KYMERA THERAPEUTICS INC501575104COM205,000$22,916,950dollars as filed
DISC MEDICINE INC COM254604101Stock270,000$17,674,200dollars as filed
TANGO THERAPEUTICS INC87583X109COM630,000$15,718,500dollars as filed
XENON PHARMACEUTICALS INC COM98420N105Stock420,000$15,619,800dollars as filed
Adlai Nortye00704R109SPONSORED ADS934,716$14,955,456dollars as filed
MIRUM PHARMACEUTICALS INC604749101COM169,450$14,484,586dollars as filed
AKTIS ONCOLOGY INC01021M104COMMON STOCK713,000$13,882,110dollars as filed
PALISADE BIO INC696389402COMMON STOCK10,276,317$13,873,028dollars as filed
ERASCA INC29479A908CALL720,000$10,555,200dollars as filedcall
BIOAGE LABS INC COM09077V100Stock1,300,000$9,217,000dollars as filed
PHARVARIS NVN69605108COMMON STOCK249,000$7,898,280dollars as filed
GYRE THERAPEUTICS INC403783103COMMON STOCK954,416$6,995,869dollars as filed
DBV TECHNOLOGIES S A23306J309SPONSORED ADS574,200$6,752,592dollars as filed
OCULAR THERAPEUTIX INC67576A100COM599,900$4,601,233dollars as filed
TREVI THERAPEUTICS INC COM89532M101Stock315,000$4,510,800dollars as filed
FAETH THERAPEUTICS INC81728A207COM NEW100,000$2,974,000dollars as filed
PRECISION BIOSCIENCES INC74019P207COM NEW430,000$2,691,800dollars as filed
UNICYCIVE THERAPEUTICS INC90466Y202COMMON STOCK275,000$1,291,125dollars as filed
GOSSAMER BIO INC COM38341P102Stock96,875$1,147,969dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001839435-26-000006this filing2026-11-16